Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04409977
Other study ID # 2018-02389
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 26, 2019
Est. completion date June 30, 2020

Study information

Verified date May 2020
Source University of Zurich
Contact Heiko Pohl, MD
Phone +41 44 255 1856
Email heiko.pohl@usz.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cluster headache attacks do not occur randomly throughout the day, but have a clear circadian rhythmicity. The aim of this study is to investigate circadian changes of the brain, the autonomic nervous system and pain processing systems.


Description:

Cluster headache attacks do not occur randomly throughout the day, but have a clear circadian rhythmicity. The aim of this study is to investigate circadian changes in the functional connectivity, spectroscopy, iron deposition and perfusion of the brain. In addition, we plan to investigate circadian changes in the pain threshold of the brain using quantitative sensory testing (QST). Finally, we will investigate changes in the autonomic nervous system measuring the pupillary response.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Diagnosis of cluster headache (CH) may enter the patient group, patients not suffering from CH may enter the control group.

- knowledge of the german language suffices to understand the information sheet and consent form

- having read, understood and signed the consent form

Exclusion Criteria:

- Pregnancy

- contraindications for the MRI scan (particularly metal splinters, ferromagnetic devices and implants)

- claustrophobia

- obesity (MRI > 35 kg/m2)

- shift working (last night shift must date back more than one week)

- jet lag (last travel over more than two time zones must date back more than one week)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
MRI examination
Patient will be scanned in the MRI twice, once at noon (+/- 1 hour), once at 1 a.m. (+/- 1 hour). The investigators will search for any changes in functional connectivity, particular regarding the connection between the hypothalamus and pain-processing networks.

Locations

Country Name City State
Switzerland University hospital Zurich Zürich Zurich

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Circadian rhythmicity of the functional connectivity of the brain Changes from baseline in functional connectivity of the brain using whole-brain fMRI Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.
Secondary Circadian rhythmicity of the pain threshold Changes from baseline of the pain threshold in the face using quantitative sensory testing (QST) Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.
Secondary Circadian changes in the perfusion of the brain. Changes from baseline in perfusion of the brain using Arterial Spin Labeled MRI Perfusion Imaging and vascular space occupancy sequences Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.
Secondary Circadian rhythmicity of the autonomic system Changes from baseline in the pupillary response (measured using pupillometry) Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.
Secondary Circadian rhythmicity of the spectroscopy of the hypothalamus Changes from baseline in the spectroscopy of the hypothalamus Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.
Secondary Circadian rhythmicity of the spectroscopy of the hypothalamus Changes from baseline in the iron concentration of the brain using quantitative susceptibility mapping Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes.
See also
  Status Clinical Trial Phase
Recruiting NCT05264714 - Cluster Headache Treatment With Rimegepant Phase 2
Completed NCT01677026 - Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
Terminated NCT00203190 - A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache Phase 4
Terminated NCT04570475 - High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache Phase 3
Completed NCT04066023 - Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches Phase 2/Phase 3
Withdrawn NCT04353505 - Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache Phase 1
Completed NCT02019017 - Botox Injection in Treatment of Cluster Headache Phase 1/Phase 2
Completed NCT05153876 - An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Recruiting NCT05324748 - Repeated GON Injections in CCH Phase 3
Completed NCT02782533 - DBS of the Third Ventricle for Cluster Headache and Obesity N/A
Completed NCT04179266 - Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache Phase 1/Phase 2
Recruiting NCT04406259 - Atrioventricular Block and Cluster Headache (SEVA) Phase 4
Recruiting NCT06206772 - Resting State Functional Connectivity in Cluster Headache
Recruiting NCT03944876 - Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache Phase 3
Not yet recruiting NCT05857098 - Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients
Recruiting NCT02910323 - The Will Erwin Headache Research Center - Cluster Headache Study
Terminated NCT00458770 - Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks N/A
Completed NCT00662935 - Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH) N/A
Active, not recruiting NCT03511846 - Pain Biomarker Study Phase 1
Completed NCT00184587 - Prophylactic Treatment of Episodic Cluster Headache Phase 2